Maternal Mortality Review Committee Dr. Nancy Gaba Confirmation Resolution of 2026
Summary
This resolution confirms the reappointment of Dr. Nancy Gaba as a member of the District of Columbia Maternal Mortality Review Committee. Specifically, it reappoints her as the committee member with experience in obstetrics and gynecology from a District hospital or birthing center, for a term ending January 2, 2029. The resolution also directs that copies be transmitted to the nominee and the Mayor and states that it takes effect immediately.
The bill is a personnel confirmation measure rather than a policy overhaul. It does not create a new program or change substantive maternal health law; instead, it maintains the membership of an existing committee established under the Maternal Mortality Review Committee Establishment Act of 2018, codified at D.C. Official Code § 7-671.02. The practical effect is to ensure continuity in the committee’s work reviewing maternal deaths and informing public health recommendations in the District.
Impact
The resolution affects the operation of the Maternal Mortality Review Committee by extending Dr. Gaba’s service in the seat reserved for an obstetrics and gynecology expert from a District hospital or birthing center. It leaves the underlying statute unchanged but supports the committee’s statutory mandate by preserving experienced membership. The measure has no direct regulatory or fiscal changes for residents, providers, or health facilities, beyond the governance implications of committee composition.
Sentiment
The available context suggests a generally positive and routine sentiment. Dr. Gaba’s extensive background in obstetrics, gynecology, medical education, and maternal health review work appears to support the nomination, and the Mayor’s legal sufficiency review found the resolution legally unobjectionable. No votes or committee transcripts were provided, and there is no indication of opposition in the record supplied.
Contention
No notable controversy is evident in the materials provided. Because this is a confirmation resolution, any discussion would likely center on the nominee’s qualifications and the importance of maintaining expertise on the Maternal Mortality Review Committee rather than on policy disputes. The record does not show dissenting views, amendments, or contested issues.
Revised for 1st substitute: Making 2025-2027 fiscal biennium operating appropriations and 2023-2025 fiscal biennium second supplemental operating appropriations.
Revised for 1st substitute: Making 2025-2027 fiscal biennium operating appropriations and 2023-2025 fiscal biennium second supplemental operating appropriations.